Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2020Pediatric Blood & CancerOpen Access

Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMariam KayleJVJhaqueline ValleSPSusan T. Paulukonis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kayle et al. (2020) studied this question.

synapsesocial.com/papers/6ab5f9c67bb3766a626cd2ebhttps://doi.org/10.1002/pbc.28152
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease2010 · 60 citations
  2. 2The Accuracy of Hospital ICD-9-CM Codes for Determining Sickle Cell Disease Genotype2017 · 40 citations
  3. 3From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea2018 · 20 citations
  4. 4Beliefs about hydroxyurea in youth with sickle cell disease2018 · 52 citations
  5. 5Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults2017 · 108 citations